KIMS NSE filing

KIMS: Voting Results of 24th AGM on Aug 27, 2026, with Strong Shareholder Approval

The RealCase readMedium impact Positive

KIMS announced voting results for its 24th AGM held on August 27, 2026. Shareholders approved audited financial statements for FY26, re-appointed Ms. Dandamudi Anitha as Director, and ratified cost auditor remuneration. Special resolutions for loans/guarantees under Section 185 and overall limits under Section 186 were also passed.

Why it matters

The announcement pertains to routine corporate governance procedures like an AGM and voting results. While important for transparency, it does not introduce new financial information or strategic shifts that would significantly alter the company's valuation in the short term. The re-appointment of a director and approval of financial statements are standard procedures.

The market read

The announcement details the successful conclusion of the AGM with strong shareholder approval for key resolutions, including financial statements and corporate actions, indicating positive corporate governance and operational continuity.

Krishna Institute of Medical Sciences Limited (KIMS) has announced the voting results and scrutinizer's report for its 24th Annual General Meeting (AGM), which was held on August 27, 2026, through Video Conferencing (VC)/Other Audio-Visual Means (OAVM).

The members transacted the business as stated in the AGM notice dated August 27, 2026. The annexed documents include the voting results as per Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the scrutinizer's report on remote e-voting and voting at the AGM. These reports are also available on the company's website.

Key resolutions passed include the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, with overwhelming support from shareholders. Additionally, Ms. Dandamudi Anitha (DIN: 00025480) was re-appointed as a Director, although this resolution saw a split vote among public institutions. The remuneration payable to the Cost Auditors, M/s. Sagar & Associates, for the financial year 2026-27 was also ratified. Special resolutions were approved for granting loans/guarantees/securities under Section 185 of the Companies Act, 2013, and for approving overall limits for loans, guarantees, securities, and investments by the company under Section 186.

Primary source

A plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.

View original filing
This is RealCase

Every move, explained.

Expert model portfolios with exact weights, an Active or Hold state on every holding, and a written reason behind every change. In your pocket.

Coming soon toApp StoreComing soon toGoogle Play
100% digital · your money stays in your own broker · your data is secure
RealCase
Your RealCases
Core Compounders
Stocks
13.4%
Flexi Core
Mutual Funds
13.1%
Latest change
ActiveHDFC Bank10% → 14%

“Deposits growing faster than loans again. We add on strength, funded from cash.”

₹0Commission · fee-only